MLH1 V384D polymorphism associates with poor response to EGFR tyrosine kinase inhibitors in patients with EGFR L858R-positive lung adenocarcinoma (Q35781614)
Jump to navigation
Jump to search
scientific article published on April 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | MLH1 V384D polymorphism associates with poor response to EGFR tyrosine kinase inhibitors in patients with EGFR L858R-positive lung adenocarcinoma |
scientific article published on April 2015 |
Statements
1 reference
MLH1 V384D polymorphism associates with poor response to EGFR tyrosine kinase inhibitors in patients with EGFR L858R-positive lung adenocarcinoma (English)
1 reference
Chao-Hua Chiu
1 reference
Hsiang-Ling Ho
1 reference
Howard Doong
1 reference
Yi-Chen Yeh
1 reference
Mei-Yu Chen
1 reference
Teh-Ying Chou
1 reference
Chun-Ming Tsai
1 reference
1 April 2015
1 reference
1 reference
6
1 reference
10
1 reference
8407-8417
1 reference
1 reference
Identifiers
1 reference
1 reference